AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on May 12, 2026

Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
Compass Therapeutics to Participate in Upcoming May Investor Events
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
Harvard Bioscience Announces First Quarter 2026 Financial Results
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Sionna Therapeutics Reports First Quarter 2026 Financial Results
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
Climb Bio to Present at Upcoming Investor Conferences

Share this page:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.